174 related articles for article (PubMed ID: 30776373)
21. Differential effects of intrathecally administered delta and mu opioid receptor agonists on formalin-evoked nociception and on the expression of Fos-like immunoreactivity in the spinal cord of the rat.
Hammond DL; Wang H; Nakashima N; Basbaum AI
J Pharmacol Exp Ther; 1998 Jan; 284(1):378-87. PubMed ID: 9435201
[TBL] [Abstract][Full Text] [Related]
22. Supraspinal antinociceptive response to [D-Pen(2,5)]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat.
Fraser GL; Pradhan AA; Clarke PB; Wahlestedt C
J Pharmacol Exp Ther; 2000 Dec; 295(3):1135-41. PubMed ID: 11082450
[TBL] [Abstract][Full Text] [Related]
23. Regulation of adenylyl cyclase, ERK1/2, and CREB by Gz following acute and chronic activation of the delta-opioid receptor.
Tso PH; Yung LY; Wong YH
J Neurochem; 2000 Apr; 74(4):1685-93. PubMed ID: 10737627
[TBL] [Abstract][Full Text] [Related]
24. Effects of U50488 and bremazocine on [Ca2+]i and cAMP in naive and tolerant rat ventricular myocytes: evidence of kappa opioid receptor multiplicity in the heart.
Zhang WM; Wu S; Yu XC; Wang HX; Bian JS; Wong TM
J Mol Cell Cardiol; 1999 Feb; 31(2):355-62. PubMed ID: 10093048
[TBL] [Abstract][Full Text] [Related]
25. Receptor-selective antagonism of opioid antinociception in female versus male rats.
Craft RM; Tseng AH; McNiel DM; Furness MS; Rice KC
Behav Pharmacol; 2001 Dec; 12(8):591-602. PubMed ID: 11856896
[TBL] [Abstract][Full Text] [Related]
26. In vitro profiling of opioid ligands using the cAMP formation inhibition assay and the β-arrestin2 recruitment assay: No two ligands have the same profile.
Kuo A; Magiera J; Rethwan N; Andersson Å; Leen Lam A; Wyse B; Meutermans W; Lewis R; Smith M
Eur J Pharmacol; 2020 Apr; 872():172947. PubMed ID: 31991138
[TBL] [Abstract][Full Text] [Related]
27. The contribution of activated peripheral kappa opioid receptors (kORs) in the inflamed knee joint to anti-nociception.
Moon SW; Park EH; Suh HR; Ko DH; Kim YI; Han HC
Brain Res; 2016 Oct; 1648(Pt A):11-18. PubMed ID: 27378583
[TBL] [Abstract][Full Text] [Related]
28. Facilitative interactions between vasoactive intestinal polypeptide and receptor type-selective opioids: implications for sensory afferent regulation of spinal opioid action.
Liu NJ; Gintzler AR
Brain Res; 2003 Jan; 959(1):103-10. PubMed ID: 12480163
[TBL] [Abstract][Full Text] [Related]
29. Prolonged morphine treatment alters δ opioid receptor post-internalization trafficking.
Ong EW; Xue L; Olmstead MC; Cahill CM
Br J Pharmacol; 2015 Jan; 172(2):615-29. PubMed ID: 24819092
[TBL] [Abstract][Full Text] [Related]
30. Effects of central administration of highly selective opioid mu-, delta- and kappa-receptor agonists on plasma luteinizing hormone (LH), prolactin, and the estrogen-induced LH surge in ovariectomized ewes.
Walsh JP; Clarke IJ
Endocrinology; 1996 Sep; 137(9):3640-8. PubMed ID: 8756528
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of mu-, delta- and kappa-opioid receptor agonists on the discriminative stimulus properties of cocaine in rats.
Suzuki T; Mori T; Tsuji M; Maeda J; Kishimoto Y; Misawa M; Nagase H
Eur J Pharmacol; 1997 Apr; 324(1):21-9. PubMed ID: 9137909
[TBL] [Abstract][Full Text] [Related]
32. mu/delta Cooperativity and opposing kappa-opioid effects in nucleus accumbens-mediated antinociception in the rat.
Schmidt BL; Tambeli CH; Levine JD; Gear RW
Eur J Neurosci; 2002 Mar; 15(5):861-8. PubMed ID: 11906528
[TBL] [Abstract][Full Text] [Related]
33. Distinct inhibition of voltage-activated Ca2+ channels by delta-opioid agonists in dorsal root ganglion neurons devoid of functional T-type Ca2+ currents.
Wu ZZ; Chen SR; Pan HL
Neuroscience; 2008 Jun; 153(4):1256-67. PubMed ID: 18434033
[TBL] [Abstract][Full Text] [Related]
34. Opioid receptor ligands in the neonatal rat spinal cord: binding and in vitro depression of the nociceptive responses.
James IF; Bettaney J; Perkins MN; Ketchum SB; Dray A
Br J Pharmacol; 1990 Mar; 99(3):503-8. PubMed ID: 2158845
[TBL] [Abstract][Full Text] [Related]
35. Axotomy reduces the effect of analgesic opioids yet increases the effect of nociceptin on dorsal root ganglion neurons.
Abdulla FA; Smith PA
J Neurosci; 1998 Dec; 18(23):9685-94. PubMed ID: 9822729
[TBL] [Abstract][Full Text] [Related]
36. Anti-exudative effects of opioid receptor agonists in a rat model of carrageenan-induced acute inflammation of the paw.
Romero A; Planas E; Poveda R; Sánchez S; Pol O; Puig MM
Eur J Pharmacol; 2005 Mar; 511(2-3):207-17. PubMed ID: 15792790
[TBL] [Abstract][Full Text] [Related]
37. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
[TBL] [Abstract][Full Text] [Related]
38. Nalfurafine prevents 5'-guanidinonaltrindole- and compound 48/80-induced spinal c-fos expression and attenuates 5'-guanidinonaltrindole-elicited scratching behavior in mice.
Inan S; Dun NJ; Cowan A
Neuroscience; 2009 Sep; 163(1):23-33. PubMed ID: 19524022
[TBL] [Abstract][Full Text] [Related]
39. In vivo evaluation of (+)-MR200 as a new selective sigma ligand modulating MOP, DOP and KOP supraspinal analgesia.
Marrazzo A; Parenti C; Scavo V; Ronsisvalle S; Scoto GM; Ronsisvalle G
Life Sci; 2006 Apr; 78(21):2449-53. PubMed ID: 16324720
[TBL] [Abstract][Full Text] [Related]
40. Opioid receptors mRNAs expression and opioids agonist-dependent G-protein activation in the rat brain following neuropathy.
Llorca-Torralba M; Pilar-Cuéllar F; da Silva Borges G; Mico JA; Berrocoso E
Prog Neuropsychopharmacol Biol Psychiatry; 2020 Apr; 99():109857. PubMed ID: 31904442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]